Pei-Ju Chien

Fu Jen Catholic University, T’ai-pei, Taipei, Taiwan

Are you Pei-Ju Chien?

Claim your profile

Publications (3)7.4 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasmapheresis not only removes circulating antibodies but also modulates cellular immunity, including lymphocyte subsets. To investigate the effect of double-filtration plasmapheresis (DFPP) on the ratio of lymphocyte subsets in patients with myasthenia gravis (MG), we examined the percentages of B-cells, T-cells, T helper (Th) cells, T suppressor (Ts) cells, natural killer (NK) cells, NKT cells, and Th/Ts ratio before and after a single DFPP session and after a course of DFPP. A total of 26 patients were recruited; their peripheral blood lymphocyte subsets were assayed using flow cytometry. After a single session of DFPP treatment, the percentages of T-cells (P = 0.0200), Th cells (P = 0.0178), and the Th/Ts ratio (P = 0.0309) decreased significantly, whereas the percentage of NK cells (P = 0.0007) increased significantly. More importantly, after one course of DFPP treatment, the reduced clinical quantitative MG (QMG) score was correlated with the decrease of the percentage of T-cells (r = 0.5005, P = 0.0092). Fourteen thymectomized MG patients had decreased percentages of T-cells (P = 0.0304) and Th cells (P = 0.0444), whereas they had increased NK cells (P = 0.0197) after a single DFPP session. Here, transiently decreased percentages of T-cells after the full DFPP course could enhance the effectiveness of plasmapheresis for MG patients.
    Artificial Organs 09/2012; · 1.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To compare immunologic phenotypes between (1) hepatocellular carcinoma (HCC) patients and a healthy population and (2) more advanced and early stage HCC patients, we studied 45 HCC patients and 46 healthy controls from January 2006 to January 2008. Using fluorescent activated cell sorter (FACS) analysis, HCC patients were demonstrated to exhibit stronger phagocytosis of granulocytes and monocytes and more peripheral blood mononuclear cells (PBMCs) in the G2/M phase compared with healthy volunteers. By contrast, lower percentages of B and T(h) lymphocytes were also found in the peripheral blood of HCC patients than in the healthy population. Most importantly, a higher percentage of B cells was found in patients with advanced HCC than in those with early HCC in terms of TNM stage (II and III vs I, p = 0.004), the Japanese Integrated Scoring system (2-3 vs 0-1, p = 0.0235), and tumor numbers (> or =2 vs 1, p = 0.005). In conclusion, our findings suggested that HCC patients might exhibit enhanced innate immunity and reduced adaptive immunity compared with healthy volunteers. A higher percentage of B cells was found in patients with more advanced HCC compared with patients with early stage HCC, which might serve as an indicator of the severity of HCC.
    Human immunology 10/2009; 71(1):58-62. · 2.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the direct impact of membrane plasmapheresis on the distribution of lymphocyte subsets, paired blood specimens from 18 healthy volunteers were studied before and immediately after a single session of double-filtration plasmapheresis (DFP). After a single session of DFP treatment, the number of helper T cells had increased by 2.34% (P = .0142), whereas the suppressor T cells decreased by 2.22% (P = .0095), with consequent increases in the T-helper/T-suppressor (Th/Ts) ratio (P < .0001). The number of B cells was also significantly increased (P = .0012) after DFP treatment; however, total T and natural killer cells did not differ after treatment. Older volunteers ( > 40 years) had significantly higher percentages of B (P = .0002) and helper T (P = .0432) cells after treatment. In contrast, younger subjects had a lower percentage of suppressor T cells (P = .0174). However, the Th/Ts ratio increased significantly irrespective of age group (P = .0016) and sex (P = .0016). A single session of membrane plasmapheresis seemed to activate the cellular immune system in our sample of 18 healthy volunteers, increasing the number of B cells and the Th/Ts ratio.
    American Journal of Clinical Pathology 12/2007; 128(6):940-4. · 2.88 Impact Factor